New targets, new drug modalities and new business strategies are drawing long-awaited attention to sickle cell disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
PowerPoint slides
Rights and permissions
About this article
Cite this article
Kingwell, K. Sickle cell solutions in sight. Nat Rev Drug Discov 15, 593–594 (2016). https://doi.org/10.1038/nrd.2016.177
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2016.177